fda guidelines semaglutide Hims & Hers stock falls 25% as curtails compounded GLP-1s FDA moves to remove GLP-1

The EMAs investigation centers on medicines that contain either semaglutide or liraglutide

Less common effects may include stomach upset, rash, itching, or a temporary feeling of warmth

Potential mechanisms of action include: Changes in Gut Microbiota: Recent studies suggest that GLP-1RAs may positively influence gut microbiota composition, which has been linked to improved metabolic health and possibly enhanced bone density

Semaglutide may produce significant weight loss as it is taken for the long term

Scientific literature increasingly frames unimolecular multi-receptor agonism as the primary route toward bariatric-like weight loss outcomes, combining appetite reduction with enhanced energy expenditure and broader metabolic effects [1, 2, 3]

medication separate